Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Augmented Effects of Virtual-reality Cycling Training on Upper Limb Motor Functions by NIBS in Patients With CP

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04101994
Recruitment Status : Recruiting
First Posted : September 25, 2019
Last Update Posted : February 7, 2020
Sponsor:
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Brief Summary:
Cerebral palsy (CP) is the most common childhood motor disability. Weakness, spasticity, and loss of dexterity are the major problems in patients with CP. A novel virtual-reality cycling training (VCT) program was to enhance promising muscle strength and motor function through promoting the participant compliance and motivation. Non-invasive brain stimulation (NIBS), such as repetitive transcranial magnetic stimulation (rTMS) and transcranial electric stimulation (TES) has potential to augment the training effects in motor neurorehabilitation via the modulation on neuroplasticity. Therefore, this study propose a novel intervention protocol to induce superior benefits on upper extremity (UE) motor function in patients with CP.

Condition or disease Intervention/treatment Phase
Cerebral Palsy Device: Virtual cycling training Device: Repetitive transcranial magnetic stimulation Device: Transcranial electric stimulation Not Applicable

Detailed Description:
This study aims to investigate the augmented effects of VCT on neuromotor control and UE motor function by NIBS in patients with CP. We hypothesize that NIBS can augment the VCT effects on neuromotor control and UE motor function in patients with CP because combined therapy integrated peripheral modification techniques (VCT) and central modulation (NIBS). These effects may further enhance the activity of daily living (ADL), participation, and health related quality of life (HRQOL). This project is executed in the following two phases: to investigate the augmented effects of VCT on neuromotor control and UE motor function in patients with CP by rTMS in phase 1 (0-1.5 years) and tCS in phase 2 (1.5-3 years).

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Augmented Effects of Virtual-reality Cycling Training on Upper Limb Motor Functions by Noninvasive Brain Stimulation in Patients With Cerebral Palsy
Actual Study Start Date : June 26, 2018
Estimated Primary Completion Date : March 6, 2022
Estimated Study Completion Date : June 6, 2022

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: VCT and real rTMS
In virtual cycling training and intermittent theta burst stimulation group (VCT + iTBS group), they received VCT and iTBS (80% of active motor threshold) on affected hemisphere.
Device: Virtual cycling training
Virtual cycling training is a convenient and easy approach for muscle strengthening.

Device: Repetitive transcranial magnetic stimulation
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Experimental: VCT and sham rTMS
In virtual cycling training and sham theta burst stimulation group (VCT + iTBS group), they received VCT and sham TBS stimulation.
Device: Virtual cycling training
Virtual cycling training is a convenient and easy approach for muscle strengthening.

Device: Repetitive transcranial magnetic stimulation
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Experimental: real rTMS
In intermittent theta burst stimulation (iTBS group), they received iTBS (80% of active motor threshold) on affected hemisphere.
Device: Repetitive transcranial magnetic stimulation
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Sham Comparator: sham rTMS
In sham theta burst stimulation (sham TBS group), they received sham TBS stimulation.
Device: Repetitive transcranial magnetic stimulation
Intermittent theta burst stimulation produces short TBS trains intermittently to facilitate cortical excitability.

Experimental: VCT and real TES
In virtual cycling training and transcranial electric stimulation group (VCT + TES group), they received TES stimulation over motor cortex.
Device: Virtual cycling training
Virtual cycling training is a convenient and easy approach for muscle strengthening.

Device: Transcranial electric stimulation
TES is a constant current with low intensity delivered to the skull through surface electrodes.

Experimental: VCT and sham TES
In virtual cycling training and sham transcranial electric stimulation group (VCT + sham TES group), they received VCT and sham TES stimulation.
Device: Virtual cycling training
Virtual cycling training is a convenient and easy approach for muscle strengthening.

Device: Transcranial electric stimulation
TES is a constant current with low intensity delivered to the skull through surface electrodes.

Experimental: real TES
In transcranial electric stimulation group (TES group), they received TES stimulation over motor cortex.
Device: Transcranial electric stimulation
TES is a constant current with low intensity delivered to the skull through surface electrodes.

Sham Comparator: sham TES
In sham transcranial electric stimulation group (sham TES group), they received sham TES stimulation.
Device: Transcranial electric stimulation
TES is a constant current with low intensity delivered to the skull through surface electrodes.




Primary Outcome Measures :
  1. Change from baseline Bruininks- Oseretsky Test of Motor Proficiency II at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Bruininks- Oseretsky Test of Motor Proficiency II (BOT-2) provides an overview of fine and gross motor skills in children and school-aged adolescents.

  2. Change from baseline Goal Attainment Scale at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    Goal Attainment Scale (GAS) is used to help a person with cerebral palsy and their family develop personal goals for therapy (for each item minimum value is -2 and maximum value is 2, higher scores mean a better outcome).


Secondary Outcome Measures :
  1. Change from baseline Melbourne Assessment 2 at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Melbourne Assessment 2 (MA2) is a valid and reliable tool for evaluating quality of upper limb movement in children with a neurological impairment aged 2.5 to 15 years.

  2. Change from baseline Quality of upper extremity skills test at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Quality of upper extremity skills test (QUEST) is an outcome measure that evaluates movement patterns and hand function in children with cerebral palsy.

  3. Change from baseline Box and block test at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Box and Block Test (BBT) measures unilateral gross manual dexterity.

  4. Change from baseline Nine-Hole test at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Nine-Hole Peg Test (NHPT) is used to measure finger dexterity in patients with various neurological diagnoses.

  5. Change from baseline Functional Independence Measure at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    Functional Independence Measure for Children:Applicable to infants and adolescents. The main purpose is to understand and track children's life function performance, progress and goal achievement. There are three main areas: self-care, mobility, and cognition. The score is from 1 to 7 points, 1 is completely dependent, and 7 is completely independent.

  6. Change from baseline Pediatric Motor Activity Log at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The Pediatric Motor Activity Log (PMAL) is a structured interview intended to examine how often and how well a child uses his/her involved upper extremity (UE) in their natural environment outside the therapeutic setting.

  7. Change from baseline ABILHAND Questionnaire at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The ABILHAND questionnaire assesses bimanual ability as an interview-based test focused on the patient's perceived difficulty. The ABILHAND-KIDS questionnaire is filled in by the parent of the child by rating the child's perceived difficulty of bimanual activities.

  8. Change from baseline Assessment of Preschool Children's Participation at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    Preferences for Activity of Children(APCP): For children between the ages of two and five, the questionnaire model is used to allow parents to circle the level. There are 45 questions in total, so that the case or parent can review the activities in the past 4 months and ask if the child have done this activity (1 point means yes, 0 points means no).

  9. Change from baseline Children Assessment of Participation and Enjoyment at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    Children Assessment of Participation and Enjoyment(CAPE): Applicable to children or adolescents between the ages of six and twenty one, through questionnaires through self-reports or interviews, a total of 55 questions, asking children about the activities involved in the past four months (1 point for yes, 0 for no).

  10. Change from baseline Cerebral Palsy Quality of Life at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The comparison of baseline of Cerebral Palsy Quality of Life for CP after different therapy.

  11. Change from baseline Motor Evoked Potential at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The comparison of baseline of Motor Evoked Potential for CP after different therapy.

  12. Change from baseline Myoton at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The comparison of baseline of Myoton for CP after different therapy.

  13. Change from baseline Hand dynamometer at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    The comparison of baseline of hand dynamometer for CP after different therapy.

  14. Change from baseline Motion analysis at after six weeks of treatment and three month [ Time Frame: baseline, after 6 weeks of treatment, 3 months ]
    All participants will be instructed to perform a series of upper-extremity tasks. The tasks include reaching and grasping. An 8-camera motion analysis system (Vicon system, 3-D Oxfort Metrics Ltd, Oxford, UK) is used in conjunction with a personal computer to capture the movement of markers placed on the participant's body; analog signals were collected simultaneously. Movements were recorded at 120 Hz and digitally low-pass filtered at 5 Hz using a second-order Butterworth filter. Reference markers are placed on the distal interphalangeal joints of the thumb and index finger, the styloid process of the ulna, proximal end of the second metacarpal, and the object.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   5 Years to 20 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of CP according to clinical criteria
  • Age 5-20 years
  • No use of botulinum toxin in the past 4 months
  • No significant perceptual or communication disturbances
  • No other peripheral or central nervous system dysfunction
  • No active inflammatory or pathologic changes in upper limb joints during the previous 6 months
  • No active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection
  • No active problems of epilepsy and EEG without epileptiform discharge

Exclusion Criteria:

  • Metabolic disorders, such as inborn error of metabolism, electrolyte, and endocrine disorders
  • Active infectious disease, such as meningitis and encephalitis
  • Patients with active medical problems, such as pneumonia, upper gastrointestinal bleeding, or urinary tract infection
  • Poor compliance or intolerance for the TMS therapy
  • Subjects with metallic implants or pregnancy.
  • EEG show epileptiform discharge
  • Patients with family history of epilipsy
  • Patients with symptoms that are restricted from tDCS, such as epilepsy, migraine and unstable health condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04101994


Contacts
Layout table for location contacts
Contact: Chia-Ling Chen, MD, PhD +886-3-3281200 ext 8148 clingchen@gmail.com

Locations
Layout table for location information
Taiwan
Chang Gung Memorial Hospital Recruiting
Taoyuan, Taiwan, 333
Contact: Chia-Ling Chen, MD, PhD    +886-3-3281200 ext 8147    clingchen@gmail.com   
Principal Investigator: Chia-Ling Chen, MD, PhD         
Sponsors and Collaborators
Chang Gung Memorial Hospital
Investigators
Layout table for investigator information
Study Director: Chia-Ling Chen, MD, PhD Chang Gung Memorial Hospital

Layout table for additonal information
Responsible Party: Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier: NCT04101994    
Other Study ID Numbers: 201701518A0
First Posted: September 25, 2019    Key Record Dates
Last Update Posted: February 7, 2020
Last Verified: January 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Chang Gung Memorial Hospital:
virtual cycling training
Non-invasive brain stimulation
repetitive transcranial magnetic stimulation
transcranial electric stimulation
Additional relevant MeSH terms:
Layout table for MeSH terms
Cerebral Palsy
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases